经济观察网 三只松鼠近日公告，公司于近日收到中国证监会出具的备案通知书，公司拟发行不超过 8154.83万股境外上市普通股并在香港联交所上市。公司自备案通知书出具之日起12个月内未完成境外 发行上市，拟继续推进的，应当更新备案材料。 ...

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [4] - Bee Assistant plans to raise no more than 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [5] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Three squirrels have received approval from the China Securities Regulatory Commission for H-share issuance, with plans to issue up to 81.5483 million shares [7] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [8] Group 2 - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind, solar, and energy storage [9] - Sains plans to invest no more than 300 million yuan in the expansion of its selection agent project [10] Group 3 - Hunan YN reports no significant changes in its internal and external operating environment [11] - Electric Power Investment has had its major asset replacement review suspended by the Shenzhen Stock Exchange due to expired financial documents [12] - Guanzhong Ecological is in the planning stage for acquiring a 51% stake in Hangzhou Actuary [13][14] Group 4 - Aima Technology's subsidiary is transferring production capacity and ceasing operations due to strategic adjustments [17] - Fosun Pharma's subsidiary has received approval for clinical trials of a new drug [18] - SAIC Group's subsidiary plans to invest 666 million yuan in the restructuring of SAIC Hongyan [19] Group 5 - Hanwei Technology plans to sell 65% of Hanwei Zhiyuan for approximately 440 million yuan [20] - Xingtong Co. has been awarded new capacity for coastal inter-provincial bulk liquid hazardous goods transportation [21][22] Group 6 - EVE Battery Investment received a cash dividend of 375 million HKD from its associate company [23] - Shanmei International's chairman has resigned due to work changes [24] - Weiye Co.'s chairman has resigned for personal reasons [25] Group 7 - Jiao Da Sino's chairman has been placed under detention [26] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [27][28] - *ST Zhengping's stock has been suspended for investigation due to abnormal price fluctuations [29] Group 8 - Zhenray Technology's chairman has had detention measures lifted [30] - Shiming Technology's chairman has had detention measures changed to a warning [31] - Nanxin Pharmaceutical is under investigation by the CSRC for suspected violations in annual report disclosures [32] Group 9 - Daqian Ecology's shareholder plans to reduce holdings by up to 3% [33] - Rundar Medical's shareholders plan to reduce holdings by up to 2.99% [34][35] - Saili Medical's shareholder plans to reduce holdings by up to 2% [36] Group 10 - Huaxin Environmental plans to repurchase shares for 40 to 80 million yuan [37] - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [38] - Zhongwu Drone has signed a significant contract worth 615 million yuan for drone systems [39]

Group 1 - Cambrian's private placement price is set at 1195.02 yuan per share, with a total fundraising amount of 3.985 billion yuan [2] - Bee Assistant plans to raise up to 984 million yuan for projects including cloud terminal computing power center and IoT terminal upgrades [3] - Kexing Pharmaceutical is planning to issue H-shares and list on the Hong Kong Stock Exchange [4] Group 2 - Three squirrels received approval from the China Securities Regulatory Commission for H-share issuance, planning to issue up to 81.5483 million shares [5] - Ruiming Technology has submitted an application for H-share issuance to the Hong Kong Stock Exchange [6] - Binhua Co. plans to invest 1.421 billion yuan in an integrated project for wind and solar energy [7] Group 3 - Sainz's subsidiary plans to invest up to 300 million yuan in the expansion of selection and extraction agents [8] - Hunan YN reported no significant changes in its internal and external operating environment [9] - Electric Power Investment plans to restructure assets and has received a notice from the Shenzhen Stock Exchange to suspend review [10] Group 4 - Guanzhong Ecology is in the planning stage to acquire 51% of Hangzhou Actuary [11] - Aima Technology announced the transfer and suspension of production capacity at its subsidiary in Guangdong [12] - Fosun Pharma's subsidiary received approval for clinical trials of a new drug [13] Group 5 - EVE Battery Investment received a cash dividend of 375 million HKD from its indirect associate, Simoer International [14] - Shanmei International announced a change in its board leadership due to personnel changes [15] - Weiye Co. announced the resignation of its chairman for personal reasons [16] Group 6 - Jiaoda Sinuo's chairman is under detention, and the company has appointed a new acting chairman [17] - Duorui Pharmaceutical is planning a change in control, leading to a stock suspension [18] - ST Zhengping's stock price has seen an abnormal increase, leading to a suspension for investigation [19] Group 7 - Daqian Ecology's shareholder plans to reduce its stake by up to 3% [20] - Rundat Medical's shareholders plan to collectively reduce their stake by up to 2.99% [21] - Seli Medical's shareholder plans to reduce its stake by up to 2% [22] Group 8 - Tianyong Intelligent has been awarded a contract worth 58.8 million yuan for an engine assembly line project [23] - Zhongwu Drone signed a significant contract worth 615 million yuan for drone systems [24]

Group 1 - The China Securities Regulatory Commission has issued a notice regarding the overseas issuance and listing of shares for Three Squirrels Co., Ltd., allowing the company to issue no more than 81,548,274 overseas listed ordinary shares and list them on the Hong Kong Stock Exchange [1] - Three Squirrels is recognized as an innovator and representative of the "full category + full channel" business model in the Chinese internet era, aiming to provide high-quality products at a good price for consumers [4] - According to data from Zhaoshang Consulting, based on sales in 2024, Three Squirrels has evolved from a single nut category to become the largest Chinese-funded snack food enterprise, with the fastest growth rate among the top five companies in the industry from 2022 to 2024 [4] Group 2 - The product portfolio of Three Squirrels includes nuts, baked goods, snack combinations, meat products, and dried fruits, with the company actively responding to market demand and consumer preferences by launching new products under multiple brands [4] - As of December 31, 2024, the company offers over 1,000 SPUs and plans to launch more than 600 new SPUs in 2024, including over 80 nut product SPUs and over 500 other snack product SPUs, along with more than 50 SPUs under the "Little Deer Blue" brand [4]

Core Viewpoint - The China Securities Regulatory Commission has issued a notice regarding the overseas listing of Three Squirrels Co., Ltd., allowing the company to issue up to 81,548,274 ordinary shares for listing on the Hong Kong Stock Exchange [1]. Company Overview - Three Squirrels is recognized as an innovator and representative of the "full category + full channel" business model in the Chinese internet era, aiming to provide high-quality products at a good price for consumers [4]. - The company has evolved from a single nut category to become the largest Chinese-funded snack food enterprise, with a projected annual compound growth rate in sales from 2022 to 2024, making it the fastest-growing company among the top five in the industry [4]. Product Portfolio - The product range of Three Squirrels includes nuts, baked goods, snack combinations, meat products, and dried fruits [4]. - The company actively anticipates and responds to market demands and consumer preferences, continuously launching new products under various brands [4]. - As of December 31, 2024, Three Squirrels offers over 1,000 Stock Keeping Units (SKUs) and plans to launch more than 600 new SKUs in 2024, including over 80 nut product SKUs and over 500 other snack product SKUs, along with more than 50 SKUs under the "Little Deer Blue" brand [4].

Core Points - Company is applying for the issuance of H-shares and plans to list on the Hong Kong Stock Exchange [1] - The company has received a notice from the China Securities Regulatory Commission regarding the overseas issuance [1] Summary by Sections - **Issuance Details** - Company plans to issue up to 81,548,274 shares for overseas listing [1] - The issuance is subject to compliance with relevant laws and regulations [1] - **Regulatory Compliance** - Company must report any significant events to the China Securities Regulatory Commission during the issuance process [1] - A report on the issuance status must be submitted within 15 working days after the completion of the overseas listing [1] - **Timeline and Updates** - If the overseas listing is not completed within 12 months from the notice date, the company must update its filing materials [1]

智通财经APP讯， 三只松鼠(300783.SZ)发布公告，公司正在申请发行H股股票并在香港联合交易所有限 公司(以下简称"香港联交所")主板挂牌上市。公司于近日收到中国证券监督管理委员会(以下简称"中国 证监会")出具的《关于三只松鼠股份有限公司境外发行上市备案通知书》。 ...

智通财经APP讯， 三只松鼠(300783.SZ)发布公告，公司正在申请发行H股股票并在香港联合交易所有限 公司(以下简称"香港联交所")主板挂牌上市。公司于近日收到中国证券监督管理委员会(以下简称"中国 证监会")出具的《关于三只松鼠股份有限公司境外发行上市备案通知书》。 ...

Core Viewpoint - The company, Three Squirrels, has received a filing notice from the China Securities Regulatory Commission (CSRC) for its plan to issue no more than 81.5483 million overseas listed ordinary shares and list them on the Hong Kong Stock Exchange [1] Group 1 - The company plans to proceed with the issuance and listing within 12 months from the date of the filing notice [1] - If the company does not complete the overseas issuance and listing within the specified timeframe, it will need to update its filing materials to continue the process [1]

三只松鼠股份有限公司 关于 H 股发行上市获得中国证监会备案的公告 证券代码：300783 证券简称：三只松鼠 公告编号：2025-049 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 三只松鼠股份有限公司（以下简称"公司"）正在申请发行 H 股股票并在香港联合交 易所有限公司（以下简称"香港联交所"）主板挂牌上市（以下简称"本次境外发行上 市"）。公司于近日收到中国证券监督管理委员会（以下简称"中国证监会"）出具的《关 于三只松鼠股份有限公司境外发行上市备案通知书》（国合函〔2025〕1671 号）（以下简 称"备案通知书"）。备案通知书主要内容如下： "一、公司拟发行不超过 81,548,274 股境外上市普通股并在香港联交所上市。 二、自备案通知书出具之日起至本次境外发行上市结束前，公司如发生重大事项，应 根据境内企业境外发行上市有关规定，通过中国证监会备案管理信息系统报告。 三、公司完成境外发行上市后 15 个工作日内，应通过中国证监会备案管理信息系统 报告发行上市情况。公司在境外发行上市过程中应严格遵守境内外有关法律、法规和规则。 四、公司自备案通 ...